|
|
|
Corporate Profile: Viragen
| Summary: |
Viragen, Inc.
is engaged in the research, development and manufacture
of immunomodulatory therapeutic products, including
natural human interferon and human monoclonal antibodies,
for the treatment of various life-threatening and
debilitating diseases such as hepatitis B & C, multiple
sclerosis, genital herpes and cancer. |
| Address:
|
865 SW 78th Avenue
Suite 100
Plantation, FL 33324 |
| Phone
#'s: |
Main |
(954) 233-8746 |
| Human Resources |
(954) 233-8746 |
| Investor Relations |
(954) 233-8746 |
| Fax
#'s: |
Main |
(954) 233-1414 |
| Human Resources |
(954) 233-1414 |
| Investor Relations |
(954) 233-1414 |
| email: |
Main |
not known |
| Human Resources |
not known |
| Investor Relations |
not known |
| Financial
information: |
| VRA |
| Patent
position: |
U.S. patents: 1976-present: patent
link. |
|
|
|
